Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Claritas Pharmaceuticals, Inc. (V.CLA) had Cash Flow from Financial Activities of 24.10M for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
-41.35M |
|
-- |
|
-- |
|
-- |
|
-6.38M |
|
-- |
|
-41.35M |
|
-41.35M |
|
-41.35M |
|
-41.35M |
|
-41.35M |
|
-41.35M |
|
-6.38M |
|
-5.93M |
|
6.21M |
|
6.21M |
|
-6.80 |
|
-6.80 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
84.71M |
|
-- |
|
-- |
|
-- |
|
99.80M |
|
-15.10M |
|
-94.87M |
|
-15.10M |
|
6.52M |
|
| Cash Flow Statement Financials | |
-7.22M |
|
-12.98M |
|
|
Cash Flow from Financial Activities |
24.10M |
0.87M |
|
4.78M |
|
3.91M |
|
11.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.95 |
|
-- |
|
-- |
|
2.34 |
|
-1.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
273.90% |
|
43.58% |
|
-48.81% |
|
-367.30% |
|
-2.32 |
|
-1.16 |
|
-1.16 |
|